State of Alaska Department of Revenue’s Catalyst Pharmaceutical CPRX Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2025
Q2 | $1.48M | Buy |
68,271
+6,148
| +10% | +$133K | 0.02% | 855 |
|
2025
Q1 | $1.51M | Sell |
62,123
-1,596
| -3% | -$38.7K | 0.02% | 810 |
|
2024
Q4 | $1.33M | Buy |
63,719
+53
| +0.1% | +$1.11K | 0.01% | 908 |
|
2024
Q3 | $1.27M | Sell |
63,666
-2,214
| -3% | -$44K | 0.01% | 941 |
|
2024
Q2 | $1.02M | Sell |
65,880
-2,158
| -3% | -$33.4K | 0.01% | 994 |
|
2024
Q1 | $1.08M | Buy |
68,038
+6,386
| +10% | +$102K | 0.01% | 985 |
|
2023
Q4 | $1.04M | Sell |
61,652
-727
| -1% | -$12.2K | 0.01% | 977 |
|
2023
Q3 | $729K | Sell |
62,379
-1,773
| -3% | -$20.7K | 0.01% | 1139 |
|
2023
Q2 | $862K | Sell |
64,152
-1,413
| -2% | -$19K | 0.01% | 1065 |
|
2023
Q1 | $1.09M | Sell |
65,565
-1,105
| -2% | -$18.3K | 0.01% | 923 |
|
2022
Q4 | $1.24M | Buy |
66,670
+1,180
| +2% | +$21.9K | 0.02% | 849 |
|
2022
Q3 | $840K | Buy |
+65,490
| New | +$840K | 0.01% | 1010 |
|